Berry Genomics Co Ltd Class A 000710
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥7.92
- Day Range
- ¥8.10–8.71
- 52-Week Range
- ¥5.40–16.48
- Bid/Ask
- ¥8.70 / ¥8.71
- Market Cap
- ¥3.08 Bil
- Volume/Avg
- 28.7 Mil / 10.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,448
- Website
- http://www.berrygenomics.com
Comparables
Valuation
|
Metric
|
000710
|
688253
|
603392
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.62 | 85.49 |
Price/Book Value | 1.49 | 2.70 | 7.57 |
Price/Sales | 2.45 | 8.00 | 34.36 |
Price/Cash Flow | 15.29 | 15.34 | 402.76 |
Price/Earnings
000710
688253
603392
Financial Strength
|
Metric
|
000710
|
688253
|
603392
|
|---|---|---|---|
Quick Ratio | 1.26 | 15.40 | 3.81 |
Current Ratio | 1.59 | 15.84 | 4.48 |
Interest Coverage | −22.62 | 2,238.82 | −59.06 |
Quick Ratio
000710
688253
603392
Profitability
|
Metric
|
000710
|
688253
|
603392
|
|---|---|---|---|
Return on Assets (Normalized) | −11.10% | 12.17% | −3.06% |
Return on Equity (Normalized) | −16.42% | 13.13% | −3.76% |
Return on Invested Capital (Normalized) | −13.75% | 12.68% | −4.05% |
Return on Assets
000710
688253
603392
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Dlgkyzlpg | Tqkg | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Wrzkblkkg | Kmqlh | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Dlrjnkhw | Wbmbz | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Cdplkzhxd | Ygklf | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Vmbzmhd | Xktm | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Rjhdwqfz | Qlpc | $28.1 Bil | |||
| Moderna Inc
MRNA
| Npmcgjrm | Kvzm | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Ywcphbsmv | Hgyv | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Ylmsmtn | Npyyv | $13.4 Bil | |||
| Incyte Corp
INCY
| Dndsdrfm | Fqckwg | $12.7 Bil |
United States